PBM Reform Is Here—What It Means for Manufacturers and Plan Sponsors
Recent U.S. policy actions are reshaping the pharmacy benefit manager landscape. New federal legislation, a proposed Department of Labor rule, and a landmark FTC settlement are signaling increased transparency, fiduciary accountability, and enforcement across PBM business practices. While these reforms stop short of dismantling the PBM model, they introduce meaningful changes that manufacturers and plan sponsors can’t ignore.
Read the full analysis to understand what’s changing—and how to prepare.
Author Team
EVERSANA employs a team of over 6000 professionals across 20+ locations around the world. From industry-leading patient service and adherence support to global pricing and revenue management, our team informs the strategies that matter…